These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 20878052)

  • 1. Effect of intrathecal baclofen, botulinum toxin type A and a rehabilitation programme on locomotor function after spinal cord injury: a case report.
    Santamato A; Panza F; Ranieri M; Amoruso MT; Amoruso L; Frisardi V; Solfrizzi V; Fiore P
    J Rehabil Med; 2010 Oct; 42(9):891-4. PubMed ID: 20878052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal Baclofen Infusion-Botulinum Toxin Combined Treatment Efficacy in the Management of Spasticity due to Cerebral Palsy.
    Marvulli R; Lagioia G; Ianieri G; Dell'Olio L; Zonno A; Riccardi M; Sinisi RB; Rizzo LB; Farì G; Megna M; Ranieri M
    CNS Neurol Disord Drug Targets; 2024; 23(7):917-926. PubMed ID: 38213169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined treatment with BTX-A and ITB for spasticity: case report.
    Gill CE; Andrade EO; Blair CR; Taylor HM; Charles D
    Tenn Med; 2007 Oct; 100(10):41-2, 44. PubMed ID: 17966716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Optimized therapy of spastic syndrome by combination intrathecal baclofen with botulinum toxin].
    Vogt T; Urban PP
    Nervenarzt; 2000 Dec; 71(12):1007-11. PubMed ID: 11139983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intrathecal baclofen in severe spasticity due to multiple sclerosis].
    Sławek J; Zieliński P; Hołub-Kucharska W; Kaniszewska J; Paczkowska M; Słoniewski P
    Neurol Neurochir Pol; 2003; 37(5):1135-42; discussion 1143. PubMed ID: 15174259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Has botulinum toxin type A a place in the treatment of spasticity in spinal cord injury patients?
    Al-Khodairy AT; Gobelet C; Rossier AB
    Spinal Cord; 1998 Dec; 36(12):854-8. PubMed ID: 9881735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spasticity following spinal cord injury.
    Rekand T; Hagen EM; Grønning M
    Tidsskr Nor Laegeforen; 2012 Apr; 132(8):970-3. PubMed ID: 22562332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of botulinum toxin type A with oral anti-spasticity medications in the management of focal spasticity.
    Dai A
    J Rehabil Med; 2007 Mar; 39(2):189; author reply 189. PubMed ID: 17351705
    [No Abstract]   [Full Text] [Related]  

  • 10. Continuous intrathecal infusion of baclofen in patients with spasticity caused by spinal cord injuries.
    Korenkov AI; Niendorf WR; Darwish N; Glaeser E; Gaab MR
    Neurosurg Rev; 2002 Aug; 25(4):228-30. PubMed ID: 12172730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Continuous intrathecal infusion of baclofen. A new therapeutic method for spasticity].
    Berg-Johnsen J; Røste GK; Solgaard T; Lundar T
    Tidsskr Nor Laegeforen; 1998 Sep; 118(21):3256-60. PubMed ID: 9772811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecal baclofen for spasticity management: a comparative analysis of spasticity of spinal vs cortical origin.
    Saval A; Chiodo AE
    J Spinal Cord Med; 2010; 33(1):16-21. PubMed ID: 20397440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal baclofen for severe spasticity secondary to spinal cord injury.
    Lewis KS; Mueller WM
    Ann Pharmacother; 1993 Jun; 27(6):767-74. PubMed ID: 8329801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of Botulinum Toxin Type A in Spasticity Caused by Spinal Cord Injury: A Randomized, Controlled Trial.
    Yan X; Lan J; Liu Y; Miao J
    Med Sci Monit; 2018 Nov; 24():8160-8171. PubMed ID: 30423587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin type A with oral baclofen versus oral tizanidine: a nonrandomized pilot comparison in patients with cerebral palsy and spastic equinus foot deformity.
    Dai AI; Wasay M; Awan S
    J Child Neurol; 2008 Dec; 23(12):1464-6. PubMed ID: 19073853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spasticity treatment facilitates direct care delivery for adults with profound intellectual disability.
    Charles PD; Gill CE; Taylor HM; Putman MS; Blair CR; Roberts AG; Ayers GD; Konrad PE
    Mov Disord; 2010 Mar; 25(4):466-73. PubMed ID: 20131401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased spasticity from a fracture in the baclofen catheter caused by Charcot spine: case report.
    Ravindra VM; Ray WZ; Sayama CM; Dailey AT
    Arch Phys Med Rehabil; 2015 Apr; 96(4):697-701. PubMed ID: 25461826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Case report of intrathecal baclofen administration in a child with severe spasticity attributable to traumatic brain injury].
    Matsuda R; Nishimura F; Hirabayashi H; Motoyama Y; Mishima H; Park YS; Nakase H; Sakaki T
    Brain Nerve; 2009 Mar; 61(3):313-5. PubMed ID: 19301603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of botulinum toxin type a in the treatment of post-stroke spasticity.
    Ward A; Roberts G; Warner J; Gillard S
    J Rehabil Med; 2005 Jul; 37(4):252-7. PubMed ID: 16024483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An introduction to trialing intrathecal baclofen in patients with hemiparetic spasticity: a description of 3 cases.
    Harned ME; Salles SS; Grider JS
    Pain Physician; 2011; 14(5):483-9. PubMed ID: 21927053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.